Mahmoud Okasha
Psychiatry · Norwich, CTNPI 1083890016
Payments from drug & device makers
Across 612 payments — averaging $2364.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$817K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$417K
- Biohaven Pharmaceutical Holding Company Ltd.$123K
- AbbVie$45K
- Biohaven Pharmaceuticals, Inc.$21K
- Amgen$15K
- plus $9K from 22 others
Across 9 payments — averaging $162.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 169 | $817,444 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 14 | $417,056 |
| Biohaven Pharmaceutical Holding Company Ltd. | 49 | $122,553 |
| AbbVie(2 entities) | 146 | $44,995 |
| Biohaven Pharmaceuticals, Inc. | 9 | $20,683 |
| Amgen | 3 | $15,000 |
| Pfizer | 7 | $5,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $618 |
| Lundbeck LLC | 32 | $580 |
| Johnson & Johnson | 22 | $385 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $355 |
| Otsuka America Pharmaceutical, Inc. | 18 | $343 |
| Vanda Pharmaceuticals Inc. | 16 | $297 |
| Neurocrine Biosciences, Inc. | 15 | $289 |
| Supernus Pharmaceuticals, Inc. | 10 | $168 |
| Sunovion Pharmaceuticals Inc. | 12 | $163 |
| Jazz Pharmaceuticals Inc. | 5 | $120 |
| Alkermes, Inc. | 6 | $108 |
| Eisai Inc. | 5 | $84 |
| Ironshore Pharmaceuticals Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Shire North American Group Inc | 4 | $64 |
| Adlon Therapeutics L.p. | 3 | $54 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Bausch Health US, LLC | 2 | $29 |
| Corium, LLC | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Merck | 1 | $12 |
How this compares
$1,447,131 in reported general payments places this provider in the 95th percentile of 644 psychiatry providers in Connecticut.
Other psychiatry in Norwich
- Kelly JaziriNorwich$21K
- Walid JaziriNorwich$17K
- Vladimir CoricNew Haven$133.7M
- Christopher VandyckNew Haven$20.8M
- Bart SloanNorwalk$6.8M
- Adam MeccaNew Haven$5.1M
- David MatuskeyFarmington$3M
- Donald AmmermanDanbury$1.5M
- Gerard SanacoraNew Haven$1.3M
- Jayesh KamathFarmington$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.